GALT · Galectin Therapeutics Inc · Earnings Calls, Transcripts & Webcasts
$2.69
-0.12 (-4.27%)
At close · Nov 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 16, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of 12 months from the issuance date of this Form 10-Q.”View the 10-Q filed Nov 16, 2026
Market Cap
$271.35M
Shares
100.88M
Volume · Nov 20
257.85K
Avg daily vol (3M)
251.29K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Galectin Therapeutics Inc Webcasts
Earnings calls, investor updates, investor days and conferences for Galectin Therapeutics Inc (GALT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-09-14
Galectin Therapeutics Inc (GALT) September 14, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q2
2025-08-14
Galectin Therapeutics Inc (GALT) Q2 2025 Earnings Call
Net income
−$7.52M
Diluted EPS
$-0.12
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-04-29
Galectin Therapeutics Inc (GALT) Q4 2020 Earnings Call
Net income
−$7.85M*
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-12-17
Galectin Therapeutics Inc (GALT) Q3 2020 Earnings Call
Net income
−$5.94M
Diluted EPS
$-0.10
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-09-29
Galectin Therapeutics Inc (GALT) Q2 2020 Earnings Call
Net income
−$6.11M
Audio
Transcript
Slides
8-K10-Q
Showing 1–5 of 5 webcasts
Key facts
CIK
1133416
CUSIP
363225202
13F (30d)
104 filings
95 filers
Visit website
Investor relations